Founded in March 1993, JHS Biomaterials develops Synthetic Hydroxyapatite-based bone grafts with a focus on serving the medical and dental areas. We work with state-of-the-art technology, valuing the production of materials with standardized quality, in addition to maintaining active research and the search for innovation. Due to the solid academic-scientific background of our founders, we always value professionals and continuous training. In addition to qualified technicians, we have a modern structure to ensure the best results. Our products are endorsed by master's dissertations, doctoral theses and papers published in congresses and scientific journals. We have a unique quality system that validates the development process for the company's suitability for new ISO certifications. The differential of our products is the ease of absorption of Synthetic Hydroxyapatite by the human body. In up to two years after surgical procedures, our grafts are fully absorbed, which generates a better quality of life, as patients gain strength and bone homogeneity. Our standout in the biotechnology market is due to the fact that we remain faithful to our values: TECHNICAL QUALITY AND THE COMMITMENT TO SAFETY AND ETHICS, ABOVE ALL.